Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors

Neuro-Oncology

Volumn 3, Issue 4, 2001, Pages 241-245

  Bodell, William J ^a,c   Giannini, Donald D ^a   Hassenbusch, Samuel ^b   Levin, Victor A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; BIOLOGICAL MARKER; CARMUSTINE; DNA; DRUG DERIVATIVE; GUANINE; N(7) HYDROXYETHYLGUANINE; N(7)-HYDROXYETHYLGUANINE;

ARTICLE; BRAIN LEVEL; BRAIN TUMOR; CHEMISTRY; DNA ADDUCT; DNA DAMAGE; DRUG EFFECT; GLIOBLASTOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY;

ANTINEOPLASTIC AGENTS, ALKYLATING; BIOLOGICAL MARKERS; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CARMUSTINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMBINED MODALITY THERAPY; DNA ADDUCTS; DNA DAMAGE; DNA, NEOPLASM; GLIOBLASTOMA; GUANINE; HUMANS; INJECTIONS, INTRALESIONAL;

EID: 0035486715     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/S1522851701000035     Document Type: Article

References (22)

1. Belanich, M., Pastor M., Randall, T., Guerra, D., Kibitel, J., Alas, L., Li, B., Citron, M., Wasserman, P., White, A., Eyre, H., Jaeckle, K., Schulman, S., Rector, D., Prados, M., Coons, S., Shapiro, W., and Yarosh, D. (1996) Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine. Cancer Res. 56, 783-788.
2. Bodell, W.J. (1990) Molecular dosimetry for sister chromatid exchange induction and cytotoxicity by monofunctional and bifunctional alkylating agents. Mutat. Res. 233, 203-210.
3. Bodell, W.J. (1999) Effect of cations on the formation of DNA alkylation products in DNA reacted with 1-(2-chloroethyl)-1-nitrosourea. Chem. Res. Toxicol. 12, 965-970.
4. Bodell, W.J., Tokuda, K., and Ludlum, D.B. (1988) Differences in DNA alkylation products formed in sensitive and resistant glioma cells treated with N-(2-chloroethyl)-N-nitrosourea. Cancer Res. 48, 4489-4492.
5. Brem, H., Ewend, M.G., Piantadosi, S., Greenhoot, J., Burger, P.C., and Sisti, M. (1995) The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial. J. Neurooncol. 26, 111-123.
6. 6-benzylguanine and its role in chemotherapy. Clin. Cancer Res. 3, 837-847.
7. Filser, J.G., Denk, B., Törnqvist, M., Kessler, W., and Ehrenberg, L. (1992) Pharmacokinetics of ethylene in man: Body burden with ethylene oxide and hydroxyethylation of hemoglobin due to endogenous and environmental ethylene. Arch. Toxicol. 66, 157-163.
8. 6-benzylguanine for patients undergoing surgery for malignant glioma. J. Clin. Oncol. 16, 3570-3575.
9. 6-methylguanine-DNA methyltransferase levels with survival of malignant astrocytoma patients treated with bis-chloroethylnitrosourea: A Southwest Oncology Group study. J. Clin. Oncol. 16, 3310-3315.
10. Kleihues, P., and Cavenee, W.K. (1997) Pathology and Genetics of Tumours of the Nervous System. Lyon, France: International Agency fo Research on Cancer. pp. 1-9.
11. Lamborn, K.R., Prados, M.D., Kaplan, S.B., and Davis, R.L. (1999) Final report on the University of California-San Francisco experience with bromode-oxyuridine labeling index as a prognostic factor for the survival of glioma patients. Cancer 85, 925-935.
12. Levin, V.A., and Prados, M.D. (1992) Treatment of recurrent gliomas and metastatic brain tumors with a polydrug protocol designed to combat nitrosourea resistance. J. Clin. Oncol. 10, 766-771.
13. Levin, V.A., Kabra, P.A., and Freeman-Dove, M.A. (1978) Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors. Cancer Chemother. Pharmacol. 1, 233-242.
14. Levin, V.A, Patlak, C.S, and Landahl, H.D. (1980) Heuristic modeling of drug delivery to malignant brain tumors. J. Pharmacokinet. Biopharm. 8, 257-296.
15. Ludlum, D.B. (1990) DNA alkylation by the haloethylnitrosoureas: Nature of modifications produced and their enzymatic repair or removal. Mutat. Res. 233, 117-126.
16. Mahaley, M.S., Jr. (1991) Neuro-oncolgy index and review (adult primary brain tumors): Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy. J. Neurooncol. 11, 85-147.
17. Nagane, M., Coufal, F., Lin, H., Bogler, O., Cavenee, W.K., and Huang, H.-J.S. (1996) A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res. 56, 5079-5086.
18. Pietronigro, D., Drnovsky, F., Cravioto, H., and Ransohoff, J. (1999) Stereotactic intratumoral injection of DTI-015 in a rat intracranial T9 gliosarcoma model. Proc. Am. Assoc. Cancer Res. 40, 583. (Abstract)
19. Rogers, L.R., Purvis, J.B., Lederman, R.J., Rosenbloom, S.A., Tomsak, R.L., Estes, M.L., Magdinec, M., Medendorp, S.V., and Boyett, J.M. (1991) Alternating sequential intracarotid BCNU and cisplatin in recurrent malignant glioma. Cancer 68, 15-21.
20. Schold, S.C., Jr., Kuhn, J.G., Chang, S.M., Bosik, M.E., Robins, H.I., Mehta, M.P., Spence, A.M., Fulton, D., Fink, K.L., and Prados, M.D. (2000) A phase I trial of 1,3 bis(2-chloroethyl)-1-nitrosourea plus temozolomide: A North American Brain Consortium study. Neuro-Oncology. [serial online], Doc. 99-26, December 9, 1999. URL http://neuro-oncology.mc.duke.edu Neuro-Oncol. 2, 34-39.
21. Wu, K.-Y., Scheller, N., Ranasinghe, A., Yen, T.-Y., Sangaiah, R., Giese, R., and Swenberg, J.A. (1999) A gas chromatography/electron capture/negative chemical ionization high-resolution mass spectrometry method for analysis of endogenous and exogenous N7-(2-hydroxyethyl)guanine in rodents and its potential for human biological monitoring. Chem. Res. Toxicol. 12, 722-729.
22. Ye, Q., and Bodell, W.J. (1997) Detection of N7-(2-hydroxyethyl)guanine adducts in DNA and 9L cells treated with 1-(2-chloroethyl)-1-nitrosourea. J. Chromatogr. B. Biomed. Sci. Appl. 694, 65-70.